Clinical Efficacy of the Erchonia EVRL for Providing Temporary Relief of Idiopathic Peripheral Neuropathy Foot Pain

NARecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

May 16, 2027

Study Completion Date

June 16, 2027

Conditions
NeuropathyNeuropathy;Peripheral
Interventions
DEVICE

Erchonia® EVRL™

The Erchonia® EVRL™ is made up of (1) 635 nanometers red laser diode and (1) 405 nanometers violet laser diode mounted in a portable handheld device. The diodes are positioned approximately 3 to 6 inches from the top of the foot. The treatments will be self-administered by the subject at his or her's place of residence, two times per day for 21 days. Each procedure administration lasts 5 minutes per foot, for a total of 10 minutes.

Trial Locations (1)

33025

RECRUITING

Franco & Co, Miramar

Sponsors
All Listed Sponsors
lead

Erchonia Corporation

INDUSTRY